newsfilter
← Latest News
GlobeNewswire·

Neumora Therapeutics to Participate in Upcoming Conferences in September

WATERTOWN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel